Yu Shyr

Moses, Shyr named to Institute of Medicine cancer therapies panel

Two Vanderbilt-Ingram Cancer Center (VICC) leaders have been named to a panel of the Institute of Medicine (IOM) to help shape national policies on the use of biomarkers for targeted cancer therapies.

Event celebrates 12 Vanderbilt endowed chair holders

Twelve Vanderbilt University faculty members named to endowed chairs were lauded for their extraordinary academic achievements during an Aug. 28 celebration.

Genomic research gains ad-“vantage” with new resources

Vanderbilt University Medical Center has stepped up its support of research aimed at cracking the mysteries of the genome, the master DNA code.

Study tracks how gene may promote lung cancer tumors

Vanderbilt-Ingram Cancer Center researchers have identified how one of the genes most commonly mutated in lung cancer may promote such tumors.

1 2